(Reuters Health) – Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.
Source: Reuters Medical News
Retirement linked to longer, better sleep
(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.
Source: Reuters Medical News
Amgen's Kyprolis improves overall survival in blood cancer patients
(Reuters) – Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.
Source: Reuters Medical News
Promising responses seen with Agios leukemia drug in study
(Reuters) – Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.
Source: Reuters Medical News
Breast reconstruction after cancer less common at cash-strapped hospitals
(Reuters Health) – Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.
Source: Reuters Medical News
Commuters often exposed to damaging noise levels
(Reuters Health) – Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.
Source: Reuters Medical News
Medical lab trade group sues over U.S. reimbursement cuts
(Reuters) – A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018.
Source: Reuters Medical News
FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved Sanofi SA’s Admelog as the first follow-on biologic version of Eli Lilly and Co’s fast-acting insulin, Humalog.
Source: Reuters Medical News
Exclusive: Philippines defied experts' advice in pursuing dengue immunization program
MANILA (Reuters) – As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation’s then health secretary Janette Garin boasted it was a world-first and a tribute to her country’s “expertise” in research.
Source: Reuters Medical News
Roche: Tecentriq cocktail slows kidney cancer progression
ZURICH (Reuters) – Combining Roche’s Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
Source: Reuters Medical News